Year |
Citation |
Score |
2020 |
Rowe L, Vera E, Acquaye A, Crandon S, Shah V, Bryla C, Wu J, Wall K, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, ... ... Aboud O, et al. The prevalence of altered body image in patients with primary brain tumors: an understudied population. Journal of Neuro-Oncology. PMID 32096067 DOI: 10.1007/S11060-020-03433-8 |
0.377 |
|
2019 |
Siegel C, Raygada M, Acquaye A, Stearn S, Wall K, Crandon S, Stevens-Brown K, Wu J, Vera L, Theeler B, Reyes J, Leggiero N, Cordova C, Bryla C, Burton E, ... ... Aboud O, et al. RARE-10. IMPROVING CARE FOR ADULT PATIENTS WITH RARE CNS TUMORS: THE NATIONAL CANCER INSTITUTE-COMPREHENSIVE ONCOLOGY NETWORK EVALUATING RARE CNS TUMORS (NCI-CONNECT) PROGRAM AND CLINIC Neuro-Oncology. 21: vi223-vi223. DOI: 10.1093/Neuonc/Noz175.933 |
0.383 |
|
2019 |
King A, Shuboni-Mulligan D, Vera E, Crandon S, Aboud O, Antony R, Boris L, Bryla C, Burton E, Cordova C, Gartland C, Grajkowska E, Penas-Prado M, Reyes J, Leggiero N, et al. QOLP-36. THE IMPORTANCE OF SLEEP DISTURBANCE IN PRIMARY BRAIN TUMOR (PBT) PATIENTS: CLINICAL CHARACTERISTICS & CO-OCCURRENCE WITH TUMOR-RELATED & PSYCHOLOGICAL SYMPTOMS Neuro-Oncology. 21: vi205-vi206. DOI: 10.1093/Neuonc/Noz175.856 |
0.34 |
|
2019 |
Aboud O, Gilbert M, Armstrong T, Vera E, Wu J, Wall K, Theeler B, Siegel C, Reyes J, Leggiero N, Crandon S, Cordova C, Boris L, Bryla C, Burton E, et al. NIMG-32. CHALLENGES OF IMAGING INTERPRETATION TO PREDICT OLIGODENDROGLIOMA GRADE Neuro-Oncology. 21: vi168-vi168. DOI: 10.1093/Neuonc/Noz175.702 |
0.303 |
|
2019 |
Vera E, Gilbert M, Aboud O, Antony R, Boris L, Bryla C, Burton E, Cordova C, Crandon S, Leggiero N, Penas-Prado M, Reyes J, Siegel C, Theeler B, Wall K, et al. HOUT-22. EVALUATING CLINICAL IMPACT UTILIZING THE RANO-PRO COLLABORATIVE’S STANDARDIZED PRIORITY CONSTRUCTS Neuro-Oncology. 21: vi116-vi117. DOI: 10.1093/Neuonc/Noz175.487 |
0.338 |
|
2019 |
Vyas Y, Vera E, Bryla C, Crandon S, Wu J, Wall K, Theeler B, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, Boris L, ... Aboud O, et al. HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS Neuro-Oncology. 21: vi112-vi112. DOI: 10.1093/Neuonc/Noz175.469 |
0.406 |
|
2018 |
Aboud O, Raffeld M, Brown J, Sabersky A, Briceno N, Brown M, Chung H, Crandon S, Ji M, Levine J, Patel S, Reyes J, Siegel C, Vera E, Xi L, et al. RARE-26. MUTATIONS IN MAPK PATHWAY GENES ARE CHARACTERISTIC AND CONFIRMATORY OF MULTINODULAR AND VACUOLATING NEURONAL TUMOR OF THE CEREBRUM Neuro-Oncology. 20: vi241-vi241. DOI: 10.1093/Neuonc/Noy148.999 |
0.333 |
|
2018 |
Acquaye A, Vera E, Aboud O, Armstrong T, Boris L, Brown M, Crandon S, Garren N, Ji M, Levine J, Romo C, Reyes J, Siegel C, Wu J, Mackey M, et al. QOLP-16. CAPTURING THE PRIMARY BRAIN TUMOR (PBT) PATIENT’S EXPERIENCE OF BODY IMAGE DISSATISFACTION: REPORT FROM THE NEURO-ONCOLOGY BRANCH-NATURAL HISTORY STUDY (NOB-NHS) Neuro-Oncology. 20: vi217-vi218. DOI: 10.1093/Neuonc/Noy148.902 |
0.355 |
|
2018 |
Mathen P, Armstrong T, Vera E, Acquaye A, Crandon S, Fletcher Ruiz M, Aboud O, Boris L, Brown M, Garren N, Ji M, Levine J, Mackey M, Romo C, Reyes J, et al. QOLP-09. ASSOCIATION BETWEEN BODY IMAGE INVESTMENT AND ALTERATION IN PATIENTS WITH PRIMARY BRAIN TUMORS Neuro-Oncology. 20: vi216-vi216. DOI: 10.1093/Neuonc/Noy148.895 |
0.375 |
|
2018 |
Rowe L, Vera E, Acquaye A, Crandon S, Fletcher Ruiz M, Aboud O, Boris L, Brown M, Garren N, Ji M, Levine J, Mackey M, Mathan P, Romo C, Reyes J, et al. QOLP-06. BODY IMAGE DISTURBANCE IN PATIENTS WITH PRIMARY BRAIN TUMORS Neuro-Oncology. 20: vi215-vi215. DOI: 10.1093/Neuonc/Noy148.892 |
0.37 |
|
2018 |
Siegel C, Aboud O, Brown M, Chung H, Raffeld M, Crandon S, Ji M, Levine J, Vera E, Patel S, Reyes J, Armstrong T, Xi L, Acquaye A, Boris L, et al. PATH-52. UTILIZING NEXT GENERATION SEQUENCING REPORTS IN CLINICAL DECISION MAKING: REPORT FROM THE NATIONAL INSTITUTES OF HEALTH (NIH) NEURO-ONCOLOGY BRANCH (NOB) NATURAL HISTORY STUDY (NHS) PRIMARY BRAIN TUMOR PANEL (PBTP) Neuro-Oncology. 20: vi170-vi170. DOI: 10.1093/Neuonc/Noy148.706 |
0.313 |
|
2018 |
Briceno N, Crandon S, Vera E, Siegel C, Aboud O, Brown M, Chung H, Ji M, Levine J, Patel S, Reyes J, Raffeld M, Gilbert M, Xi L, Armstrong T. INNV-43. NUCLEIC ACID ADEQUACY FROM ARCHIVED FORMALIN-FIXED PARAFFIN EMBEDDED (FFPE) TUMOR TISSUE FOR NEXT-GENERATION SEQUENCING (NGS) IN NATIONAL CANCER INSTITUTE (NCI)- NATURAL HISTORY STUDY (NHS) OF PRIMARY CNS TUMOR Neuro-Oncology. 20: vi146-vi146. DOI: 10.1093/Neuonc/Noy148.611 |
0.313 |
|
2018 |
Crandon S, Vera E, Acquaye A, Siegel C, Aboud O, Boris L, Brown M, Garren N, Ji M, Levine J, Romo C, Reyes J, Wu J, Gilbert M, Armstrong T. HOUT-12. CHARACTERIZATION OF SYMPTOM BURDEN IN MINORITY PATIENTS WITH CNS TUMORS: A REPORT FROM THE NEURO-ONCOLOGY BRANCH (NOB) NATURAL HISTORY STUDY (NHS) Neuro-Oncology. 20: vi115-vi115. DOI: 10.1093/Neuonc/Noy148.480 |
0.383 |
|
2012 |
Aboud O, Mrak RE, Boop F, Griffin ST. Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. Bmc Medicine. 10: 35. PMID 22502727 DOI: 10.1186/1741-7015-10-35 |
0.474 |
|
Show low-probability matches. |